Mylan / Minnesota Law Review / St. Louis University Law Journal / University of Pittsburgh Law Review / Medtronic Inc. / Mova Pharm / Schering-Plough Corp. / Valley Drug Co. / Eli Lilly & Co. / /
Country
United States / /
Event
Patent Issuance / FDA Phase / Patent Filing / /
IndustryTerm
would-be generic drug manufacturer / pharmaceutical patents / pharmaceutical industry / drug product / pharmaceutical patent litigation procedures / generic product / drug law / generic manufacturers / drug must demonstrate that the product / pharmaceutical / generic manufacturer / generic pharmaceuticals / pharmaceuticals / pharmaceutical patent litigation / generic version / brand-name pharmaceutical / antitrust law / generic pharmaceutical / pharmaceutical patent settlements / pharmaceutical patent expert / pharmaceutical patent litigation settlements / federal food / generic products / /
Organization
Center for Drug Evaluation & Research / U.S. Patent and Trademark Office / Federal Trade Commission / Medicare / Congress / University of Pittsburgh / UN Court / FDA / Congressional Research Service / Washington University / Department of Health / St. Louis University / /
Person
Wendy H. Schacht / Duke Law / Douglas A. Robinson / Jacob S. Wharton / William B. Vogt / Eric M. Solovy / Sarah E. Eurek / R. Thomas Visiting Scholar January / Kent S. Bernard / Brian Porter / Willard K. Tom / Laura J. Robinson / Natalie M. Derzko / James J. Wheaton / John R. Thomas / John Fazzio / Kristin E. Behrendt / G. Lee Skillington / Justina A. Molzon / Alfred B. Engelberg / Jonathan M. Lave / /
. Pharmaceutical Patent Litigation Settlements: Implications for Competition and Innovation John R. Thomas Visiting Scholar